Related Experiment Video
Updated: Oct 8, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Molecular Mechanisms and Epigenetic Regulation in Diabetic Cardiomyopathy
Anupam Mittal1, Rajni Garg2, Ajay Bahl3
1Department of Translational and Regenerative Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Insights
Type 2 diabetes contributes to cardiovascular issues like diabetic cardiomyopathy (DbCM). This review explores how epigenetic modifications, including DNA methylation and non-coding RNAs, influence DbCM development and progression.
Area of Science:
- Cardiovascular Science
- Metabolic Disorders
- Epigenetics
Background:
- Type 2 diabetes mellitus (DM) is a major lifestyle disease linked to cardiovascular diseases (CVD).
- Diabetic cardiomyopathy (DbCM) is a cardiac complication of DM, characterized by cardiac remodeling independent of other comorbidities.
- DbCM involves impaired cardiac metabolism, mitochondrial dysfunction, oxidative stress, inflammation, apoptosis, and autophagy.
Purpose of the Study:
- To review the role of epigenetic modifications in the pathogenesis of diabetic cardiomyopathy (DbCM).
- To elucidate how epigenetic mechanisms regulate molecular pathways involved in DbCM.
Main Methods:
- Literature review focusing on epigenetic mechanisms in DbCM.
- Analysis of studies investigating histone modifications (acetylation, methylation), DNA methylation, and non-coding RNAs in DbCM.
Main Results:
- Epigenetic modifiers are critical in DbCM development.
- Histone modifications, DNA methylation, and non-coding RNAs significantly impact molecular pathways underlying DbCM pathophysiology.
Conclusions:
- Epigenetic modifications play a crucial role in the development and progression of diabetic cardiomyopathy.
- Targeting epigenetic mechanisms offers potential therapeutic strategies for managing DbCM in diabetic patients.
Abstract:
Diabetes mellitus (DM) is an important lifestyle disease. Type 2 diabetes is one of the prime contributors to cardiovascular diseases (CVD) and diabetic cardiomyopathy (DbCM) and leads to increased morbidity and mortality in patients with DM. DbCM is a typical cardiac disease, characterized by cardiac remodeling in the presence of DM and in the absence of other comorbidities such as hypertension, valvular diseases, and coronary artery disease. DbCM is associated with defective cardiac metabolism, altered mitochondrial structure and function, and other physiological and pathophysiological signaling mechanisms such as oxidative stress, inflammation, myocardial apoptosis, and autophagy. Epigenetic modifiers are crucial players in the pathogenesis of DbCM. Thus, it is important to explore the role of epigenetic modifiers or modifications in regulating molecular pathways associated with DbCM. In this review, we have discussed the role of various epigenetic mechanisms such as histone modifications (acetylation and methylation), DNA methylation and non-coding RNAs in modulating molecular pathways involved in the pathophysiology of the DbCM.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Epigenetic Regulation
X-chromosome...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Coronary Artery Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy